STAAR Surgical Company (STAA) Financials
STAA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-01-31 | 488.7 million | 102.7 million |
2023-10-31 | 471.5 million | 92.9 million |
2023-07-31 | 440.7 million | 87.0 million |
2023-04-30 | 418.9 million | 80.0 million |
STAA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-01-31 | 28.9 million | 182000 |
2023-10-31 | -15.2 million | 8.8 million |
2023-07-31 | -9.3 million | 8.4 million |
2023-04-30 | -8.0 million | 6.1 million |
STAA Net Income
No data available :(
STAA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-01-31 | 220.7 million | - | - |
2023-10-31 | 188.1 million | - | 35.8 million |
2023-07-31 | 192.0 million | - | 35.9 million |
2023-04-30 | 203.8 million | - | 32.5 million |
STAA Shares Outstanding
STAA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-01-31 | 3.1 million | 10.9 million | 16.9 million | 22.6 million |
2023-10-31 | 9.2 million | 11.5 million | 19.3 million | 26.6 million |
2023-07-31 | 3.0 million | 11.8 million | 18.1 million | 32.3 million |
2023-04-30 | 2.9 million | 10.3 million | 18.1 million | 26.4 million |
STAA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-01-31 | 76.3 million | 15.5 million |
2023-10-31 | 80.3 million | 16.7 million |
2023-07-31 | 92.3 million | 21.6 million |
2023-04-30 | 73.5 million | 16.0 million |
STAA
Price: $45.51
52 week price:
Earnings Per Share: 0.43 USD
P/E Ratio: 81.18
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 638969
Ebitda: 1.9 millionMarket Capitalization: 2.2 billion